Skip Navigation

Publicaciones covid-9

Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students

Sarah C. TinkerComments to Author , Christine M. Szablewski, Anastasia P. Litvintseva, Cherie Drenzek, Gary E. Voccio, Melissa A. Hunter, Stephen Briggs, Debbie E. Heida, Jennifer Folster, Patricia L. Shewmaker, Magdalena Medrzycki, Michael D. Bowen, Caitlin Bohannon, Dennis Bagarozzi, Marla Petway, Paul A. Rota, Wendi Kuhnert-Tallman, Natalie Thornburg, Jessica L. Prince-Guerra, Lisa C. Barrios, Azaibi Tamin, Jennifer L. Harcourt, Margaret A. Honein, and CDC Sample Collection Team,1 and CDC Surge Laboratory Group1
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.C. Tinker, C.M. Szablewski, A.P. Litvintseva, J. Folster, P.L. Shewmaker, M. Medrzycki, M.D. Bowen, C. Bohannon, D. Bagarozzi Jr., M. Petway, P.A. Rota, W. Kuhnert-Tallman, N. Thornburg, J.L. Prince-Guerra, L.C. Barrios, A. Tamin, J.L. Harcourt, M.A. Honein); Georgia Department of Public Health, Atlanta (C.M. Szablewski, C. Drenzek); Georgia Department of Public Health Northwest Health District, Rome, Georgia, USA (G.E. Voccio, M.A. Hunter); Berry College, Mount Berry, Georgia, USA (S. Briggs, D.E. Heida)
?  Evaluación: (not yet rated)
Resumen

We used the BinaxNOW COVID-19 Ag Card to screen 1,540 asymptomatic college students for severe acute respiratory syndrome coronavirus 2 in a low-prevalence setting. Compared with reverse transcription PCR, BinaxNOW showed 20% overall sensitivity; among participants with culturable virus, sensitivity was 60%. BinaxNOW provides point-of-care screening but misses many infections.

Procedencia del autor
Tipo de documento
Especialidad(es)
Observaciones Este articulo no tiene pdf
Publicado en el sitio 2021-09-09 19:04:55

Comentarios

(aún no hay comentarios disponibles para este recurso)